# Randomized Phase III Placebo-Controlled Trial of Carboplatin and Paclitaxel With or Without the Vascular Disrupting Agent Vadimezan (ASA404) in Advanced Non–Small-Cell Lung Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/randomized-phase-iii-placebo-controlled-trial-of-carboplatin-and-paclitaxel-with/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Primo N. Lara,Jean‐Yves Douillard,Kazuhiko Nakagawa,Joachim von Pawel,Mark J. McKeage,István Albert,György Losonczy,Martin Reck,Dae Seog Heo,Xiaolin Fan,Abderrahim Fandi,Giorgio V. Scagliotti |
| Citations | 321 |
| DOI | 10.1200/jco.2011.35.0660 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2011.35.0660?role=tab |
| OpenAlex ID | https://openalex.org/W2111512928 |
| PMID | 21709202 |
| Type | article |
| Year | 2011 |

## Paper authors

- [Dae Seog Heo](https://scholariq.org/researchers/dae-seog-heo/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.